Analystreport

Cellular Biomedicine Group Inc (NASDAQ: CBMG) is now covered by analysts at B. Riley. They set a "buy" rating and a $32.00 price target on the stock.

CELLULAR BIOMEDICINE GROUP INC  (CBMG) 
Last cellular biomedicine group inc earnings: 11/6 04:25 pm Check Earnings Report
US:NASDAQ Investor Relations: cellbiomedgroup.com/investor-relations